Engineered Extracellular Vesicles for Tissue Regeneration
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Regenerative Engineering".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 83
Special Issue Editor
Special Issue Information
Dear Colleagues,
The journal Bioengineering is pleased to announce a call for manuscripts for an upcoming Special issue on "Engineered Extracellular Vesicles for Tissue Regeneration". This Special Issue aims to bring together cutting-edge research and reviews that explore the innovative approaches, mechanisms, and applications of engineered extracellular vesicles (EVs) in the field of tissue regeneration.
Extracellular vesicles, including exosomes and microvesicles, are nano-sized particles naturally released by cells that play a crucial role in intercellular communication. Their unique ability to transfer bioactive molecules such as proteins, lipids, and RNAs makes them promising candidates for therapeutic applications. Recent advancements in bioengineering have opened new avenues for enhancing the regenerative potential of EVs, making them a focal point in regenerative medicine.
We are pleased to invite researchers, scientists, and clinicians to submit their manuscipts. This Special Issue seeks to provide a comprehensive overview of the current state of the art and future prospects in the field of engineered extracellular vesicles for tissue regeneration and innovations.
In this Special Issue, original research articles and reviews are welcome. Research areas may include, but not limited to the following: (1) Engineering Techniques for EVs: Methods for modifying and enhancing EVs, including genetic engineering, surface modification, and cargo loading strategies. (2) Mechanisms of Action: Insights into the molecular and cellular mechanisms through which engineered EVs promote tissue regeneration. (3) Therapeutic Applications: Use of engineered EVs in the regeneration of various tissues, such as bone, cartilage, muscle, nerve, and cardiac tissue. (4) EVs in Stem Cell Therapy: Role of engineered EVs in enhancing the efficacy of stem cell-based therapies. (5) Preclinical and Clinical Studies: Experimental studies and clinical trials evaluating the safety, efficacy, and therapeutic potential of engineered EVs. (6) Biomaterials and Scaffolds: Integration of engineered EVs with biomaterials and scaffolds for improved tissue regeneration outcomes. (7) EVs in Disease Models: Application of engineered EVs in disease models to understand their regenerative capabilities. (8) Challenges and Future Directions: Current challenges in the field and future perspectives for the clinical translation of engineered EVs.
We look forward to receiving your contributions to this exciting and rapidly evolving field. Submissions will undergo a rigorous peer-review process to ensure the publication of high-quality research. Detailed submission guidelines and formatting requirements can be found on our journal’s website.
Prof. Dr. Mikko J. Lammi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracellular vesicles
- tissue regeneration
- bioengineering
- nanotechnology
- stem cells
- cell therapy
- drug delivery
- biomaterials
- regenerative medicine
- therapeutic applications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
